Respiratory Muscle Training in Subacute Stroke Patients
RETORNUS
The RETORNUS Study: Dual Training to Restore the Function of Respiratory Muscles in Stroke Patients
2 other identifiers
interventional
129
1 country
1
Brief Summary
This study is divided for development in two complementary work packages justified by the need to incorporate new strategies to optimize rehabilitation outcomes in stroke patients. The general objectives are: 1) to determine the prevalence of respiratory muscle dysfunction in stroke patients; 2) to identify the existence of a potential amino acid marker of increased risk of muscle dysfunction after suffering a stroke; 3) to evaluate the effectiveness of incorporating the respiratory muscle training as an innovative adjuvant therapy in stroke rehabilitation program that may decrease the incidence of morbidity and mortality in the medium and long term; and 4) to quantify the potential impact of respiratory muscle training on the costs of care for stroke patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 23, 2014
CompletedFirst Posted
Study publicly available on registry
April 29, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedFebruary 17, 2016
February 1, 2016
2.8 years
April 23, 2014
February 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Respiratory muscle strength
Respiratory muscle strength is assessed through maximal inspiratory and expiratory pressures (MIP and MEP, respectively) using a pressure transducer connected to a digital register system. The MIP is measured at mouth during a maximum effort from residual volume against occluded airway. To determine the MEP, the patients will perform a maximum expiratory effort from total lung capacity (TLC) in the face of the occluded airway. A specific and validated respiratory pressures manometer will be used (Micro RPM, Cardinalhealth, Kent, UK). For the purposes of the study, 'responders' will include the group of patients with an increase of 25% or more in respiratory muscle strength (MIP and MEP). Measures will be done once every week
3 weeks
Secondary Outcomes (4)
Handgrip strength assessment
3 weeks
Lower limb strength measurement
3 weeks
Serum aminoacids analysis
Up to 3 weeks
Adverse events as a measure of safety and tolerability
18 months after discharge
Study Arms (2)
Inspiratory Muscle Training (IMT)
SHAM COMPARATORPatients with subacute stroke in a neurorehabilitation setting.
High-intensity IMT
EXPERIMENTALPatients with subacute stroke in a neurorehabilitation setting.
Interventions
Sham IMT at a fixed workload of 10 cmH2O. 5 sets of 10 repetitions, twice a day, 7 days per week, for 4 weeks.
High Intensity IMT. The training load is the maximum inspiratory load defined according to patient tolerance. This load will be equivalent to 10 maximal repetitions (RM) as 10 consecutive inspirations (x 5 sessions), twice a day.
Eligibility Criteria
You may qualify if:
- Hemiplegia secondary to first ischemic stroke in the subacute phase, and
- informed consent signed by the candidates of the study, after receiving full information on objectives, techniques and possible consequences.
You may not qualify if:
- Serious cardiovascular, neuromuscular or metabolic conditions that could interfere with the results and/or interfere with the measurements,
- significant alcohol abuse (\> 80 g/day) or severe malnutrition, and
- treatment with drugs with potential effect on muscle structure and function (steroids, anabolic steroids, thyroid hormones and immunosuppressants).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Physical Medicine and Rehabilitation Dpt. Parc de Salut Mar, Hospital del Mar
Barcelona, Barcelona, 08003, Spain
Related Publications (26)
Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010 Jan;9(1):105-18. doi: 10.1016/S1474-4422(09)70266-2.
PMID: 20083041BACKGROUNDMartino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005 Dec;36(12):2756-63. doi: 10.1161/01.STR.0000190056.76543.eb. Epub 2005 Nov 3.
PMID: 16269630BACKGROUNDTeixeira-Salmela LF, Parreira VF, Britto RR, Brant TC, Inacio EP, Alcantara TO, Carvalho IF. Respiratory pressures and thoracoabdominal motion in community-dwelling chronic stroke survivors. Arch Phys Med Rehabil. 2005 Oct;86(10):1974-8. doi: 10.1016/j.apmr.2005.03.035.
PMID: 16213241BACKGROUNDTerre R, Mearin F. Oropharyngeal dysphagia after the acute phase of stroke: predictors of aspiration. Neurogastroenterol Motil. 2006 Mar;18(3):200-5. doi: 10.1111/j.1365-2982.2005.00729.x.
PMID: 16487410BACKGROUNDIndredavik B, Rohweder G, Naalsund E, Lydersen S. Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke. 2008 Feb;39(2):414-20. doi: 10.1161/STROKEAHA.107.489294. Epub 2007 Dec 20.
PMID: 18096834BACKGROUNDMartin BJ, Corlew MM, Wood H, Olson D, Golopol LA, Wingo M, Kirmani N. The association of swallowing dysfunction and aspiration pneumonia. Dysphagia. 1994 Winter;9(1):1-6. doi: 10.1007/BF00262751.
PMID: 8131418BACKGROUNDSchmidt J, Holas M, Halvorson K, Reding M. Videofluoroscopic evidence of aspiration predicts pneumonia and death but not dehydration following stroke. Dysphagia. 1994 Winter;9(1):7-11. doi: 10.1007/BF00262752.
PMID: 8131429BACKGROUNDDall'Ago P, Chiappa GR, Guths H, Stein R, Ribeiro JP. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol. 2006 Feb 21;47(4):757-63. doi: 10.1016/j.jacc.2005.09.052. Epub 2006 Jan 26.
PMID: 16487841BACKGROUNDChiara T, Martin AD, Davenport PW, Bolser DC. Expiratory muscle strength training in persons with multiple sclerosis having mild to moderate disability: effect on maximal expiratory pressure, pulmonary function, and maximal voluntary cough. Arch Phys Med Rehabil. 2006 Apr;87(4):468-73. doi: 10.1016/j.apmr.2005.12.035.
PMID: 16571384BACKGROUNDLogemann JA. Treatment of oral and pharyngeal dysphagia. Phys Med Rehabil Clin N Am. 2008 Nov;19(4):803-16, ix. doi: 10.1016/j.pmr.2008.06.003.
PMID: 18940642BACKGROUNDCarnaby G, Hankey GJ, Pizzi J. Behavioural intervention for dysphagia in acute stroke: a randomised controlled trial. Lancet Neurol. 2006 Jan;5(1):31-7. doi: 10.1016/S1474-4422(05)70252-0.
PMID: 16361020BACKGROUNDWheeler KM, Chiara T, Sapienza CM. Surface electromyographic activity of the submental muscles during swallow and expiratory pressure threshold training tasks. Dysphagia. 2007 Apr;22(2):108-16. doi: 10.1007/s00455-006-9061-4. Epub 2007 Feb 10.
PMID: 17294298BACKGROUNDHuckabee ML, Doeltgen S. Emerging modalities in dysphagia rehabilitation: neuromuscular electrical stimulation. N Z Med J. 2007 Oct 12;120(1263):U2744.
PMID: 17972964BACKGROUNDShaw GY, Sechtem PR, Searl J, Keller K, Rawi TA, Dowdy E. Transcutaneous neuromuscular electrical stimulation (VitalStim) curative therapy for severe dysphagia: myth or reality? Ann Otol Rhinol Laryngol. 2007 Jan;116(1):36-44. doi: 10.1177/000348940711600107.
PMID: 17305276BACKGROUNDLogemann JA. The effects of VitalStim on clinical and research thinking in dysphagia. Dysphagia. 2007 Jan;22(1):11-2. doi: 10.1007/s00455-006-9039-2. Epub 2007 Jan 10. No abstract available.
PMID: 17216392BACKGROUNDEngelen MP, Orozco-Levi M, Deutz NE, Barreiro E, Hernandez N, Wouters EF, Gea J, Schols AM. Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease. Eur Respir J. 2004 Apr;23(4):545-51. doi: 10.1183/09031936.04.00022204.
PMID: 15083752BACKGROUNDKargotich S, Keast D, Goodman C, Bhagat CI, Joske DJ, Dawson B, Morton AR. Monitoring 6 weeks of progressive endurance training with plasma glutamine. Int J Sports Med. 2007 Mar;28(3):211-6. doi: 10.1055/s-2006-924218. Epub 2006 Oct 6.
PMID: 17024635BACKGROUNDHolm E, Hack V, Tokus M, Breitkreutz R, Babylon A, Droge W. Linkage between postabsorptive amino acid release and glutamate uptake in skeletal muscle tissue of healthy young subjects, cancer patients, and the elderly. J Mol Med (Berl). 1997 Jun;75(6):454-61. doi: 10.1007/s001090050131.
PMID: 9231886BACKGROUNDRutten EP, Franssen FM, Engelen MP, Wouters EF, Deutz NE, Schols AM. Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 2006 Apr;83(4):829-34. doi: 10.1093/ajcn/83.4.829.
PMID: 16600935BACKGROUNDFiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994 Jun 23;330(25):1769-75. doi: 10.1056/NEJM199406233302501.
PMID: 8190152BACKGROUNDOuellette MM, LeBrasseur NK, Bean JF, Phillips E, Stein J, Frontera WR, Fielding RA. High-intensity resistance training improves muscle strength, self-reported function, and disability in long-term stroke survivors. Stroke. 2004 Jun;35(6):1404-9. doi: 10.1161/01.STR.0000127785.73065.34. Epub 2004 Apr 22.
PMID: 15105515BACKGROUNDBurgomaster KA, Hughes SC, Heigenhauser GJ, Bradwell SN, Gibala MJ. Six sessions of sprint interval training increases muscle oxidative potential and cycle endurance capacity in humans. J Appl Physiol (1985). 2005 Jun;98(6):1985-90. doi: 10.1152/japplphysiol.01095.2004. Epub 2005 Feb 10.
PMID: 15705728BACKGROUNDWeiner P, Magadle R, Berar-Yanay N, Davidovich A, Weiner M. The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD. Chest. 2000 Sep;118(3):672-8. doi: 10.1378/chest.118.3.672.
PMID: 10988188BACKGROUNDGosselink R. Respiratory rehabilitation: improvement of short- and long-term outcome. Eur Respir J. 2002 Jul;20(1):4-5. doi: 10.1183/09031936.02.00402002. No abstract available.
PMID: 12166579BACKGROUNDKim J, Sapienza CM. Implications of expiratory muscle strength training for rehabilitation of the elderly: Tutorial. J Rehabil Res Dev. 2005 Mar-Apr;42(2):211-24. doi: 10.1682/jrrd.2004.07.0077.
PMID: 15944886BACKGROUNDSapienza CM, Davenport PW, Martin AD. Expiratory muscle training increases pressure support in high school band students. J Voice. 2002 Dec;16(4):495-501. doi: 10.1016/s0892-1997(02)00125-x.
PMID: 12512637BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Esther Duarte, MD, PhD
Institut Hospital del Mar d'Investigacions Mèdiques. Universitat Autònoma de Barcelona.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 23, 2014
First Posted
April 29, 2014
Study Start
March 1, 2011
Primary Completion
December 1, 2013
Study Completion
September 1, 2014
Last Updated
February 17, 2016
Record last verified: 2016-02